Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care

March 21, 2024 updated by: Melinda Stanley, Baylor College of Medicine
The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.

Study Overview

Detailed Description

Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older adults. Anxiety in older adults is associated with decreased physical activity, poorer self-perceptions of health, decreased life satisfaction, and increased loneliness. Because many older adults with anxiety seek assistance in a medical setting, treatment has been primarily pharmacological. There is, however, limited evidence of the effectiveness of psychotropic medications. Given the potential difficulties in prescribing psychotropic medications in later life (e.g., increased adverse effects, potential drug interactions), psychosocial treatments may be important alternative or adjuncts.

The treatment phase of this study lasts 10 weeks, during which patients will be randomly assigned to either cognitive behavior therapy (CBT) or usual care. Follow-up will last 12 months after treatment completion, during which time patients will complete telephone assessments.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Houston Center for Quality of Care and Utilization Studies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Clinical diagnosis of Generalized Anxiety Disorder

Exclusion Criteria:

  • Active suicidal intent
  • Current psychosis
  • Current bipolar disorder
  • Substance abuse within past month
  • Cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 2
Usual Care
Biweekly telephone calls to monitor symptom severity, an enhanced Usual Care condition
Experimental: 1
Cognitive Behavior Therapy
8 to 10 in person CBT sessions up to 60 minutes in duration within a 12 week time period
Other Names:
  • CBT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Anxiety
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Functional and health status
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months
Satisfaction with CBT and general health care
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months
Service utilization
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months
Depression
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months
Sleep quality
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months
Use of alcohol and other substances
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months
Quality of life inventory (QOLI)
Time Frame: Baseline and 3, 6, 9, 12 and 15 months
Baseline and 3, 6, 9, 12 and 15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2004

Primary Completion (Actual)

January 1, 2008

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

March 28, 2006

First Submitted That Met QC Criteria

March 28, 2006

First Posted (Estimated)

March 30, 2006

Study Record Updates

Last Update Posted (Actual)

March 22, 2024

Last Update Submitted That Met QC Criteria

March 21, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H15958
  • R01MH053932 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on Cognitive Behavior Therapy

3
Subscribe